Stephen Johnson syndrome, also known as toxic epidermal necrolysis (TEN), is a rare and potentially life-threatening skin condition. It is characterized by widespread blistering of the skin, which can lead to serious complications if left untreated.
The exact cause of Stephen Johnson syndrome is still unknown, but it is believed to be triggered by an allergic reaction or hypersensitivity to certain medications, infections, or environmental factors.
The symptoms of Stephen Johnson syndrome typically begin within 1-3 weeks after exposure to the trigger factor. They can include fever, headache, fatigue, and a general feeling of being unwell.
In severe cases, patients may experience widespread blistering, which can lead to dehydration, electrolyte imbalances, and even organ failure if left untreated.
The treatment for Stephen Johnson syndrome typically involves supportive care, such as fluid replacement and pain management. In severe cases, hospitalization may be necessary to monitor vital signs and prevent complications.
It is essential to identify the trigger factor and remove it to prevent further progression of the condition.